title: [Pelvic lymph node dissection (extended vs standard) and prostate cancer].
abstract: The role and the potential benefit, if any, of pelvic lymphadenectomy in prostate cancer are still controversially discussed. It is generally accepted that PLND at time of radical prostatectomy is the only reliable diagnostic procedure to achieve as much individual histological staging information as possible to trigger postoperative adjuvant management. However, the extent of pelvic lymph node dissection (limited vs. extended) and the most suitable candidates for this procedure are still a matter of intense debate. The aim of this review is to critically evaluate the current status on lymph node dissection in prostate cancer.
authors.affiliation: Departamento de Urología, Clínica Universitaria de Navarra, Pamplona. arincon@unav.es
authors.forename: A
authors.initials: A
authors.lastname: Rincón Mayans
authors.forename: J J
authors.initials: JJ
authors.lastname: Zudaire Bergera
authors.forename: J
authors.initials: J
authors.lastname: Rioja Zuazu
authors.forename: B
authors.initials: B
authors.lastname: Zudaire Diaz-Tejeiro
authors.forename: J
authors.initials: J
authors.lastname: Barba Abad
authors.forename: X
authors.initials: X
authors.lastname: Brugarolas Rosselló
authors.forename: D
authors.initials: D
authors.lastname: Rosell Costa
authors.forename: J M
authors.initials: JM
authors.lastname: Berián Polo
mesh_terms: D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000601:surgery*